The Evolving Post-PCI Antithrombotic Therapies.
Publication
, Journal Article
Ohman, EM
Published in: N Engl J Med
October 28, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 28, 2021
Volume
385
Issue
18
Start / End Page
1712 / 1714
Location
United States
Related Subject Headings
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ohman, E. M. (2021). The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med, 385(18), 1712–1714. https://doi.org/10.1056/NEJMe2112747
Ohman, E Magnus. “The Evolving Post-PCI Antithrombotic Therapies.” N Engl J Med 385, no. 18 (October 28, 2021): 1712–14. https://doi.org/10.1056/NEJMe2112747.
Ohman EM. The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med. 2021 Oct 28;385(18):1712–4.
Ohman, E. Magnus. “The Evolving Post-PCI Antithrombotic Therapies.” N Engl J Med, vol. 385, no. 18, Oct. 2021, pp. 1712–14. Pubmed, doi:10.1056/NEJMe2112747.
Ohman EM. The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med. 2021 Oct 28;385(18):1712–1714.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 28, 2021
Volume
385
Issue
18
Start / End Page
1712 / 1714
Location
United States
Related Subject Headings
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences